New search Hide text from Guidelines
C CARDIOVASCULAR SYSTEMThis group comprises substances used for the treatment of cardiovascular conditions.
Drugs used for the treatment of hypertension are classified in C02 - Antihypertensives, C03 - Diuretics, C07 - Beta blocking agents, C08 - Calcium channel blockers, and C09 - Agents acting on the renin-angiotensin system. For the classification of combination products of antihypertensives from different ATC groups, the following ranking should be used, from higher to lower precedence: C09, C07, C08, and C03.
C04 PERIPHERAL VASODILATORS
C04A PERIPHERAL VASODILATORS
This group comprises plain and combined preparations used in the treatment of cerebrovascular or peripheral circulatory disorders.
Combinations with Antihypertensives, see C02 - Antihypertensives.
Combinations with vasodilators used in cardiac diseases, see C01DA.
| The DDDs are based on the doses used for the treatment of cerebral and peripheral vascular disorders. |
C04AE Ergot alkaloids
Includes combinations with other peripheral vasodilators.
Combinations with calcium channel blockers are classified in C08CA.
Combinations of cinnarizine and dihydroergcristine are classified in N07CA52.
See also G02AB and N02CA.
| ATC code | Name | DDD | U | Adm.R | Note |
| C04AE01 | ergoloid mesylates | 3 | mg | O | |
| 3 | mg | P | |||
| C04AE02 | nicergoline | ||||
| C04AE04 | dihydroergocristine | ||||
| C04AE51 | ergoloid mesylates, combinations | ||||
| C04AE54 | dihydroergocristine, combinations |
Last updated: 2024-01-26